Newsroom
The Latest News From the Ivy Center
The Ivy Brain Tumor Center at Barrow Neurological Institute strives to be a valuable resource for any brain tumor or brain cancer-related media needs. Our media relations team is happy to help answer questions and arrange interviews. The expert neurosurgeons, neuro-oncologists and scientists at the Ivy Center are available to speak on a variety of topics.
Our state-of-the-art media studio is available for audio and video interviews. We can also arrange filming opportunities at various locations around the center and labs.
To contact the media relation team, call Melinda Langdon at 623-297-1317 or email: [email protected].
Please see below for the latest media coverage and news from the Ivy Center. To read about our inspiring patients and those behind the scenes at the Ivy Center, visit the Ivy Blog.
Ivy Brain Tumor Center Awarded U.S. Department of Defense Grant to Advance Promising Glioblastoma Drug Candidate
The Ivy Brain Tumor Center received a $1.48 million, three-year U.S. Department of Defense (DoD) Impact Award to advance the development of MnP3. This novel redox-active agent shows potential in the treatment of glioblastoma. Successful completion of the project will have a significant impact on translating the drug to clinical use.
Bringing Empathy to Brain Surgery
The Working Mom Hour Podcast featured Dr. Charuta Furey, a neurosurgery resident at Barrow Neurological Institute and the Ivy Brain Tumor Center. From navigating tough conversations with families to balancing the demands of her career with motherhood, Dr. Furey's insights offer invaluable guidance. She dives into the significance of empathy in patient care and the importance of preparation for surgery and provides practical strategies for both medical professionals and patients alike. Listen now!
Michelle Palacino featured on Rare Enough Podcast
Michelle Palacino, a dedicated caregiver in the brain tumor community and an employee at the Ivy Brain Tumor Center, was recently featured on the "Rare Enough" podcast, hosted by DJ Stewart for Head for the Cure. In this episode, Michelle discusses her personal experiences and the challenges she faces, highlighting her steadfast commitment to combating brain cancer.
Two female neuro-oncologists strive to develop new therapies for aggressive brain tumors
Featured in Women in Onc on Healio, Dr. Kelly Braun and Dr. Yoshie Umemura of the Ivy Brain Tumor Center at Barrow Neurological Institute are at the forefront of developing new treatments for aggressive brain tumors, such as glioblastoma. Their focus on translational clinical research strives to rapidly convert laboratory breakthroughs into clinical applications. They share insights on mentorship, teamwork, and the crucial balance between professional duties and personal life, providing invaluable guidance for women aspiring to leadership roles in oncology.
Ivy Brain Tumor Center Announces Promising Data for Niraparib in Phase 0/2 Glioblastoma Clinical Trial
The Ivy Brain Tumor Center at Barrow Neurological Institute announces promising results from a collaborative Phase 0/2 trial of niraparib, supported by GSK, in patients with newly diagnosed glioblastoma with unmethylated MGMT.
Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma
The Ivy Brain Tumor Center announced the first patient has been treated in a novel Phase 0/1 clinical trial of BDTX-1535, an experimental drug targeting oncogenic EGFR (epidermal growth factor receptor) mutations in patients with recurrent high-grade glioma.
FOX 10 News | Dbacks’ Donation in Honor of Nicole Hazen Funds Groundbreaking Brain Tumor Research
In a feature by FOX10 News, Dr. Nader Sanai, Director of the Ivy Brain Tumor Center, discussed the impactful support from the Arizona Diamondbacks. Their ongoing contributions are crucial in advancing Dr. Sanai's leading-edge research, particularly following their latest donation in memory of Nicole Hazen. This robust partnership underscores significant progress in brain tumor treatment, positioning the Ivy Center at the forefront of brain cancer care.
Center focused on finding cure for glioblastoma reveals AstraZeneca drug may be a success
Outsourcing Pharma recently spotlighted the Ivy Center's groundbreaking clinical trial on AZD1390 for recurrent glioblastoma patients. The Ivy Center unveiled promising initial results, indicating that AZD1390 may act as a potent radio-sensitizer in human glioblastoma cases. This discovery marks the first instance where AZD1390's potential efficacy in enhancing radiation therapy for glioblastoma has been documented in humans. These results highlight the Ivy Center's commitment to pioneering advancements in glioblastoma treatment.
Ivy Brain Tumor Center Announces Results of Phase 0/1 Study in Recurrent Glioblastoma Patients at the European Society for Medical Oncology (ESMO) 2023 Congress
The Ivy Brain Tumor Center announced initial results from a Phase 0/1 clinical trial of the Ataxia telangiectasia mutated (ATM) kinase inhibitor AZD1390 in recurrent glioblastoma in combination with radiation therapy.
Arizona Physician Podcast features Yoshie Umemura, MD, on Clinical Trials for Neuro-Oncology
Dr. Yoshie Umemura, Chief Medical Officer at the Ivy Center, was highlighted in an episode of the Arizona Physician Podcast. During the discussion, Dr. Umemura shared insights into her motivation for pursuing a career in neuro-oncology, her reasons for joining the Ivy Center, and her strategic plans to advance the clinical trials program. Her efforts focus on pioneering new treatments for brain cancer, including glioblastoma, through innovative research and patient care.